Europa Stream

 

Interview: Dr. Guillermo Moreno-Sanz, Zerenia Clinic

Zerenia Clinic is a UK-based private healthcare provider specialising in treatments with cannabis-based medicinal products (CBMP). Last year it attained the UK’s first ever NHS reimbursement for cannabis flowers. In an interview with HBI, Dr. Guillermo Moreno-Sanz, Scientific Director at Zerenia’s parent company, Khiron Europe (a pharma company producing CBMPs), spoke about the growing opportunity in Europe’s medicinal cannabis space.

Addressing healthcare workforce inefficiency through AI and 3d indoor mapping – a conversation with Connie Moser of Navenio

Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]

CVC Capital acquires major stake in Indonesia’s Siloam Hospitals, signalling rising PE interest in Southeast Asia healthcare

CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.

Caresyntax secures $180 million in Series C extension

Caresyntax, a Berlin-based vendor-neutral surgery technology platform, has successfully raised $180 million in a Series C extension and growth debt expansion round. The financing comprises $80 million in equity and up to $100 million in a growth debt facility. 

Challenges in German healthcare system present opportunities for tech-focused investors

Germany's healthcare system, known for its efficiency and quality, is currently facing substantial challenges, as highlighted by a recent McKinsey survey. The survey, conducted from November 2022 to January 2023, involved 201 physicians from various specialties and ages across Germany. While not representative, it included a diverse group of doctors.

Bain Capital eyes controlling stake in India’s HCG from CVC Capital

Bain Capital, the American private investment firm, is the leading candidate to acquire a 60.4% controlling stake in India-based cancer care provider HealthCare Global Enterprises (HCG), from CVC Capital Partners, a Luxembourg-based private equity and investment advisory firm, CNBCTV18 reported. The stake is said to have been valued at approximately $356 million, while HCG’s market value stands at $589 million despite a 3% drop in its share price this year. Negotiations are ongoing, and the deal is not yet finalised. 

Germany’s pharmaceutical company STADA expands its presence in MENA region

STADA, a European pharmaceutical company based in Germany, has acquired the FITO™ trademark from Leo Pharma, a multinational Danish pharmaceutical company, to expand its consumer healthcare presence in the Middle East and North Africa (MENA) region.  International law firm Bird & Bird has advised STADA Group on acquiring the FITO business from Leo Pharma in an asset deal.

Find Us